Skip to main content
Equibles

Parallel Advisors, LLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1690010 SAN FRANCISCO, CA
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$31
+$13 QoQ
Shares Held
103
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 95 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,928,308 across 168 Biotechnology names. RNAC ranks #161 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CORT
Corcept Therapeutics Inc
 3,962,177 $344,511,290
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 5,389 $2,676,877
3 RCUS
Arcus Biosciences, Inc.
 86,557 $2,668,552
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,063 $662,823
5 KRYS
Krystal Biotech, Inc.
 1,699 $631,467
6 ARGX
Argenx SE
 640 $593,772
7 INCY
Incyte Corp
 4,961 $562,378
8 VKTX
Viking Therapeutics, Inc.
 13,833 $539,625

All Filings in RNAC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31 103
2026-03-31 $18 103
2025-12-31 $22 103
2025-09-30 $31 103
2025-06-30 $31 103
2025-03-31 $39 3
2024-12-31 $53 3
2024-09-30 $48 3
2024-06-30 $81 3
2024-03-31 $64 100
2023-12-31 $137 200
2023-09-30 $105 100
2023-06-30 $111 100
2023-03-31 $138 100
2022-12-31 $112 100
2022-09-30 $163 100
2022-06-30 $130 100
2022-03-31 $122 100
2021-12-31 $325 100
2021-09-30 $415 100
2021-06-30 $417 100
2021-03-31 $452 100
2020-12-31 $605 200